Deployment of convalescent plasma for the prevention and treatment of COVID-19Evan M. Bloch, Aaron A.R. Tobian, Shmuel Shoham et al.|Journal of Clinical Investigation|2020Cited by 863
Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor populationSabra L. Klein, Aaron A.R. Tobian, Andrew Pekosz et al.|Journal of Clinical Investigation|2020Cited by 480
SARS-CoV-2–specific CD8+ T cell responses in convalescent COVID-19 individualsHassen Kared, Thomas C. Quinn, David Sullivan et al.|Journal of Clinical Investigation|2021Cited by 276
Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing TitersEshan U. Patel, Oliver Laeyendecker, Evan M. Bloch et al.|Journal of Clinical Microbiology|2020Cited by 198
Metabolic programs define dysfunctional immune responses in severe COVID-19 patientsElizabeth A. Thompson, Jonathan D. Powell, Katherine Cascino et al.|Cell Reports|2021Cited by 135